Treatment of relapsed/refractory severe aplastic anemia in children: Evidence‐based recommendations-Reference-Cited by-同舟云学术

Treatment of relapsed/refractory severe aplastic anemia in children: Evidence‐based recommendations

Published:2024-05-19 Issue:8 Volume:71 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Shimano Kristin A.¹^ORCID,Sasa Ghadir²,Broglie Larisa³^ORCID,Gloude Nicholas J.⁴,Myers Kasiani⁵^ORCID,Nakano Taizo A.⁶^ORCID,Sharathkumar Anjali⁷^ORCID,Rothman Jennifer A.⁸^ORCID,Pereda Maria A.⁶,Overholt Kathleen⁹,Narla Anupama¹⁰,McGuinn Catherine¹¹,Lau Bonnie W.¹²^ORCID,Geddis Amy E.¹³,Dror Yigal¹⁴^ORCID,de Jong Jill L. O.¹⁵,Castillo Paul¹⁶^ORCID,Allen Steven W.¹⁷,Boklan Jessica¹⁸^ORCID

Affiliation:

1. Department of Pediatrics, Division of Allergy Immunology, and Bone Marrow Transplant University of California San Francisco Benioff Children's Hospital San Francisco California USA

2. Sarah Cannon Transplant and Cellular Therapy Network San Antonio Texas USA

3. Department of Pediatric Hematology/Oncology/Blood and Marrow Transplantation Medical College of Wisconsin Milwaukee Wisconsin USA

4. Department of Pediatrics University of California San Diego Rady Children's Hospital San Diego California USA

5. Department of Pediatrics Division of Bone Marrow Transplantation and Immune Deficiency University of Cincinnati College of Medicine Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

6. Department of Pediatrics, Center for Cancer and Blood Disorders Children's Hospital Colorado Aurora Colorado USA

7. Stead Family Department of Pediatrics University of Iowa Carver College of Medicine Iowa City Iowa USA

8. Division of Pediatric Hematology/Oncology Duke University Medical Center Durham North Carolina USA

9. Department of Pediatrics, Pediatric Hematology/Oncology Riley Hospital for Children at Indiana University Indianapolis Indiana USA

10. Department of Pediatrics Stanford University School of Medicine Stanford California USA

11. Department of Pediatrics, Division of Pediatric Hematology Oncology Weill Cornell Medicine New York New York USA

12. Department of Pediatrics, Pediatric Hematology‐Oncology Dartmouth‐Hitchcock Lebanon Pennsylvania USA

13. Department of Paediatrics Division of Hematology/Oncology Cancer and Blood Disorders Center Seattle Children's Hospital Seattle Washington USA

14. Department of Pediatrics, Marrow Failure and Myelodysplasia Program The Hospital for Sick Children Toronto Canada

15. Department of Pediatrics Section of Hematology/Oncology/Stem Cell Transplantation University of Chicago Chicago Illinois USA

16. Department of Pediatrics, Division of Pediatric Hematology Oncology UF Health Shands Children's Hospital Gainesville Florida USA

17. Department of Pediatrics, Pediatric Hematology/Oncology University of Pittsburgh School of Medicine UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania USA

18. Department of Pediatrics, Center for Cancer and Blood Disorders Phoenix Children's Hospital Phoenix Arizona USA

Abstract

AbstractSevere aplastic anemia (SAA) is a rare potentially fatal hematologic disorder. Although overall outcomes with treatment are excellent, there are variations in management approach, including differences in treatment between adult and pediatric patients. Certain aspects of treatment are under active investigation in clinical trials. Because of the rarity of the disease, some pediatric hematologists may have relatively limited experience with the complex management of SAA. The following recommendations reflect an up‐to‐date evidence‐based approach to the treatment of children with relapsed or refractory SAA.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.31075

Reference80 articles.

1. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality

2. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)

3. Paediatric amendment to adult BSH Guidelines for aplastic anaemia

4. Guidelines for the diagnosis and management of adult aplastic anaemia

5. Management of aplastic anemia after failure of frontline immunosuppression